| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Fuller RW, Hines CW, Mill... |
Lowering of Brain Serotonin Levels by Chloramphetamines |
Biochem Pharmacol |
1965 |
| Barfknecht CF, Nichols DE |
Potential psychotomimetics, Bromomethoxyamphetamines |
J Med Chem |
1971 |
| Barfknecht CF, Nichols DE |
Potential psychotomimetics. Bromomethoxyamphetamines |
J Med Chem |
1971 |
| Sreenivasan VR |
Problems in Identification of Methylenediony and Methoxy Amphetamines |
Journal of Criminal ... |
1972 |
| Schmidt CJ, Sonsalla PK, ... |
Methamphetamine-induced depression of monoamine synthesis in the rat: ... |
J Neurochem |
1985 |
| Stone DM, Merchant KM, Ha... |
Immediate and long-term effects of 3,4-methylenedioxymethamphetamine o... |
Neuropharmacology |
1987 |
| Buchanan JF, Brown CR |
'Designer drugs'. A problem in clinical toxicology |
Med Toxicol Adverse ... |
1988 |
| Scallet AC, Lipe GW, Ali ... |
Neuropathological evaluation by combined immunohistochemistry and dege... |
Neurotoxicology |
1988 |
| Schmidt CJ, Taylor VL |
Direct central effects of acute methylenedioxymethamphetamine on serot... |
Eur J Pharmacol |
1988 |
| Fitzgerald RL, Blanke RV,... |
Determination of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxym... |
J Chromatogr |
1989 |
| Johnson M, Stone DM, Bush... |
Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced n... |
Eur J Pharmacol |
1989 |
| Schmidt CJ |
Acute and long-term neurochemical effects of methylenedioxymethampheta... |
NIDA Res Monogr |
1989 |
| Stone DM, Hanson GR, Gibb... |
In vitro reactivation of rat cortical tryptophan hydroxylase following... |
J Neurochem |
1989 |
| Gibb JW, Stone DM, Johnso... |
Role of dopamine in the neurotoxicity induced by amphetamines and rela... |
NIDA Res Monogr |
1989 |
| Callaway CW, Wing LL, Gey... |
Serotonin release contributes to the locomotor stimulant effects of 3,... |
J Pharmacol Exp Ther |
1990 |
| Nash JF, Meltzer HY, Gude... |
Effect of 3,4-methylenedioxymethamphetamine on 3,4-dihydroxyphenylalan... |
J Neurochem |
1990 |
| Schmidt CJ, Abbate GM, Bl... |
Selective 5-hydroxytryptamine2 receptor antagonists protect against th... |
J Pharmacol Exp Ther |
1990 |
| Schmidt CJ, Black CK, Tay... |
Antagonism of the neurotoxicity due to a single administration of meth... |
Eur J Pharmacol |
1990 |
| Schmidt CJ, Kehne JH |
Neurotoxicity of MDMA: neurochemical effects |
Ann N Y Acad Sci |
1990 |
| Johnson MP, Frescas SP, O... |
Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... |
J Med Chem |
1991 |
| Johnson MP, Frescas SP, O... |
Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... |
J Med Chem |
1991 |
| Pan HS, Wang RY |
The action of (+/-)-MDMA on medial prefrontal cortical neurons is medi... |
Brain Res |
1991 |
| Schechter MD |
Effect of serotonin depletion by p-chlorophenylalanine upon discrimina... |
Gen Pharmacol |
1991 |
| Schmidt CJ, Taylor VL, Ab... |
5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-m... |
J Pharmacol Exp Ther |
1991 |
| Schmidt CJ, Black CK, Tay... |
The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-... |
Eur J Pharmacol |
1992 |
| Schmidt CJ, Fadayel GM, S... |
5-HT2 receptors exert a state-dependent regulation of dopaminergic fun... |
Eur J Pharmacol |
1992 |
| Zhao ZY, Castagnoli N Jr,... |
Synthesis and neurotoxicological evaluation of putative metabolites of... |
Chem Res Toxicol |
1992 |
| Bohn M, Bohn G, Blaschke ... |
Synthesis markers in illegally manufactured 3,4-methylenedioxyamphetam... |
Int J Legal Med |
1993 |
| Huang X, Nichols DE |
5-HT2 receptor-mediated potentiation of dopamine synthesis and central... |
Eur J Pharmacol |
1993 |
| Shiue CY, Shiue GG, Rysav... |
Fluorine-18 and carbon-11 labeled amphetamine analogs--synthesis, dist... |
Nucl Med Biol |
1993 |
| Marona-Lewicka D, Nichols... |
Behavioral effects of the highly selective serotonin releasing agent 5... |
Eur J Pharmacol |
1994 |
| Schmidt CJ, Sullivan CK, ... |
Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increa... |
J Neurochem |
1994 |
| White SR, Duffy P, Kaliva... |
Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firi... |
Neuroscience |
1994 |
| Green AR, Cross AJ, Goodw... |
Review of the pharmacology and clinical pharmacology of 3,4-methylened... |
Psychopharmacology (... |
1995 |
| Miller RT, Lau SS, Monks ... |
Effects of intracerebroventricular administration of 5-(glutathion-S-y... |
Chem Res Toxicol |
1996 |
| Gudelsky GA, Nash JF |
Carrier-mediated release of serotonin by 3,4-methylenedioxymethampheta... |
J Neurochem |
1996 |
| Obradovic T, Imel KM, Whi... |
Methylenedioxymethamphetamine-induced inhibition of neuronal firing in... |
Neuroscience |
1996 |
| Gifford AN, Minabe Y, Too... |
Examination of the action of 3,4-methylenedioxymethamphetamine on rat ... |
Synapse |
1996 |
| Geyer MA |
Serotonergic functions in arousal and motor activity |
Behav Brain Res |
1996 |
| Obradovic T, Imel KM, Whi... |
Methylenedioxymethamphetamine-induced inhibition of neuronal firing in... |
Neuroscience |
1996 |
| Muck-Seler D, Takahashi S... |
The effect of MDMA (3,4-methylenedioxymethamphetamine) on the 5-HT syn... |
Brain Res |
1998 |
| Sprague JE, Everman SL, N... |
An integrated hypothesis for the serotonergic axonal loss induced by 3... |
Neurotoxicology |
1998 |
| Sabol KE, Seiden LS |
Reserpine attenuates D-amphetamine and MDMA-induced transmitter releas... |
Brain Res |
1998 |
| Westwood SC, Hanson GR |
Effects of stimulants of abuse on extrapyramidal and limbic neuropepti... |
J Pharmacol Exp Ther |
1999 |
| Nishisawa S, Mzengeza S, ... |
Acute effects of 3,4-methylenedioxymethamphetamine on brain serotonin ... |
Neurochem Int |
1999 |
| Schirren CA, Berghaus TM,... |
Thrombotic thrombocytopenic purpura after Ecstasy-induced acute liver ... |
Ann Intern Med |
1999 |
| Erdtmann-Vourliotis M, Ma... |
Acute injection of drugs with low addictive potential (delta(9)-tetrah... |
Brain Res Mol Brain ... |
1999 |
| Aalberg L, DeRuiter J, No... |
Chromatographic and Mass Spectral Methods of Identification for the Si... |
J Chromatogr Sci |
2000 |
| Christophersen AS |
Amphetamine designer drugs - an overview and epidemiology |
Toxicol Lett |
2000 |
| Kuhn DM, Geddes TJ |
Molecular footprints of neurotoxic amphetamine action [In Process Cita... |
Ann N Y Acad Sci |
2000 |
| O'Shea E, Easton N, Fry J... |
Protection against 3,4-methylenedioxymethamphetamine-induced neurodege... |
J Neurochem |
2002 |
| Boot BP, Mechan AO, McCan... |
MDMA- and p-chlorophenylalanine-induced reduction in 5-HT concentratio... |
Eur J Pharmacol |
2002 |
| Lebsanft HB, Mayerhofer A... |
Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unila... |
J Neural Transm |
2003 |
| Easton N, Fry J, O'Shea E... |
Synthesis, in vitro formation, and behavioural effects of glutathione ... |
Brain Res |
2003 |
| Dafters RI, Biello SM |
The effect of 3,4-methylenedioxymethamphetamine ('Ecstasy') on seroton... |
Neurosci Lett |
2003 |
| Moyano S, Frechilla D, De... |
NMDA receptor subunit and CaMKII changes in rat hippocampus induced by... |
Psychopharmacology (... |
2004 |
| Garcia-Osta A, Del Rio J,... |
Increased CRE-binding activity and tryptophan hydroxylase mRNA express... |
Brain Res Mol Brain ... |
2004 |
| Burchett SA, Hicks TP |
The mysterious trace amines: protean neuromodulators of synaptic trans... |
Prog Neurobiol |
2006 |
| Freudenmann RW, Oxler F, ... |
The origin of MDMA (ecstasy) revisited: the true story reconstructed f... |
Addiction |
2006 |
| Capela JP, Macedo C, Bran... |
Neurotoxicity mechanisms of thioether ecstasy metabolites |
Neuroscience |
2007 |
| Ambrose JB, Bennett HD, L... |
Cerebral vasculopathy after 4-bromo-2,5-dimethoxyphenethylamine ingest... |
Neurologist |
2010 |
| Heather E, Shimmon R, McD... |
Organic Impurity Profiling of 3,4-Methylenedioxymethamphetamine ... |
Forensic Sci Int |
2020 |
